I used to be in $ATHX for their phase 3 trial in IS with stemcell. Unfortunately the trial failed despite its very interesting approach. I can remember that it took ages to find enough patients even though they had also widened the treatment window to approx. 18 hours.
I look very much forward to the continuation of this AGN trial and that the trial will meet its endpoints.
- Forums
- ASX - By Stock
- Ann: DSMB Confirms Safety of First Patients Dosed
I used to be in $ATHX for their phase 3 trial in IS with...
Featured News
Add AGN (ASX) to my watchlist
|
|||||
Last
84.5¢ |
Change
-0.025(2.87%) |
Mkt cap ! $107.4M |
Open | High | Low | Value | Volume |
89.0¢ | 89.0¢ | 84.0¢ | $151.6K | 172.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 705 | 84.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
88.0¢ | 28508 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 400 | 0.845 |
1 | 10000 | 0.840 |
1 | 22000 | 0.835 |
1 | 5005 | 0.815 |
2 | 20012 | 0.810 |
Price($) | Vol. | No. |
---|---|---|
0.880 | 28508 | 2 |
0.885 | 3986 | 1 |
0.890 | 13752 | 2 |
0.895 | 5000 | 1 |
0.900 | 23644 | 2 |
Last trade - 15.55pm 15/08/2024 (20 minute delay) ? |
Featured News
AGN (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online